Partners Bancorp Reports Results of Operations for the Second Quarter 2023

Stock Information for Adaptimmune Therapeutics plc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Adaptimmune Therapeutics plc

LINKBANCORP, Inc. and Partners Bancorp Complete Transformational Combination
LINKBANCORP, Inc. and Partners Bancorp Announce Receipt of Federal Reserve Board Approval and Closing Date for Merger of Equals
Partners Bancorp Reports Results of Operations for the Third Quarter 2023
LINKBANCORP, Inc. and Partners Bancorp Announce Receipt of FDIC and State Regulatory Approvals for Merger of Equals
LINKBANCORP, Inc. and Partners Bancorp Announce Receipt of Shareholder Approvals for Merger of Equals
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - CWBR, FOCS, PTRS, ARNC
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - REUN, ARNC, PTRS, FOCS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PTRS, LSI, CHRA

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.